{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:44:40Z","timestamp":1779378280087,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002554","name":"AIDS Healthcare Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["T32 DA0233561"],"award-info":[{"award-number":["T32 DA0233561"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["T32 DA0233561"],"award-info":[{"award-number":["T32 DA0233561"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R25MH067127"],"award-info":[{"award-number":["R25MH067127"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01MH126768"],"award-info":[{"award-number":["R01MH126768"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R25MH067127"],"award-info":[{"award-number":["R25MH067127"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BEAT-HIV Collaboratory, co-funded by NIAID, NIMH, NINDS and NIDA","award":["UM1AI126620"],"award-info":[{"award-number":["UM1AI126620"]}]},{"name":"San Diego Center for AIDS Research (SD CFAR), funded by NIAID","award":["P30AI036214"],"award-info":[{"award-number":["P30AI036214"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Most HIV cure-related studies involve interrupting antiretroviral treatment to assess the efficacy of pharmacologic interventions \u2013 also known as analytical treatment interruptions (ATIs). ATIs imply the risk of passing HIV to sexual partners due to the loss of undetectable HIV status. There has been a notable lack of attention paid to perceptions of ATIs among racial, ethnic, sex and gender minorities, and HIV serodifferent couples. These populations are among those most impacted by HIV in the United States. Future HIV cure research paradigms should equitably include considerations from these groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From August \u2013 October 2020, we conducted in-depth interviews with 10 racial, ethnic, sex, and gender minority HIV serodifferent couples in geographically diverse regions of the United States to understand their perspectives about ATIs and partner protection measures to prevent secondary HIV transmissions because of participation in ATI studies. We used framework analysis to analyze the qualitative data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 10 couples recruited, four identified as a gay couple, two as a gay and bisexual couple, two as a heterosexual couple, one as a gay and queer couple, and one as a queer couple. We found that HIV serodifferent couples in our study viewed ATIs as contradicting HIV treatment adherence messages. Couples expressed discomfort around ATIs in HIV cure research. They were concerned with the return of HIV detectability and worried ATIs might result in secondary HIV transmission. Participants were strongly in favor of using a range of partner protection measures during ATIs that included PrEP, HIV risk reduction counseling, and alternatives for penetrative sex practices. Couples also recommended that sex partners be consulted or involved as part of ATI trials.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings highlight new potential opportunities and strategies to mitigate risk of HIV transmission during ATIs among key groups historically under-represented in HIV cure research. Findings also underscore the relational aspects of ATI trials. We provide preliminary considerations for planning ATI trials with diverse HIV serodifferent partners. Future studies should continue to explore these issues among other types of partnerships, cultures, and socio-cultural settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13528-8","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T05:06:59Z","timestamp":1657343219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["\u201cIt comes altogether as one:\u201d perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States"],"prefix":"10.1186","volume":"22","author":[{"given":"Danielle M.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia D.","family":"Cowlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dionicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena M.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila K.","family":"Stockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith D.","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Sauceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory O.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"issue":"9","key":"13528_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"M Cohen","year":"2016","unstructured":"Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Al E. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"13528_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/aid.2011.0017","volume":"27","author":"DM Margolis","year":"2011","unstructured":"Margolis DM. Eradication therapies for HIV infection: time to begin again. AIDS Res Hum Retrovir. 2011;27(4):347\u201353.","journal-title":"AIDS Res Hum Retrovir"},{"key":"13528_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MA, et al. Research priorities for an HIV cure: international AIDS society global scientific strategy 2021. Nat Med. 2021;27:2085\u201398.","journal-title":"Nat Med"},{"issue":"4","key":"13528_CR4","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2352-3018(19)30052-9","volume":"6","author":"B Julg","year":"2019","unstructured":"Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, et al. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials \u2014 report of a consensus meeting. Lancet HIV. 2019;6(4):e259\u201368.","journal-title":"Lancet HIV"},{"key":"13528_CR5","volume-title":"Research Toward a Cure Trials","author":"TAG","year":"2021","unstructured":"TAG. Research Toward a Cure Trials. 2021. Available from: http:\/\/www.treatmentactiongroup.org\/cure\/trials"},{"issue":"7","key":"13528_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiz262","volume":"220","author":"L Dee","year":"2019","unstructured":"Dee L, Boone CA, Palm D, Campbell D, Dub\u00e9 K. Secondary HIV infection and mitigation in cure-related HIV trials during analytical treatment interruptions. J Infect Dis. 2019;220(7):34\u20137.","journal-title":"J Infect Dis"},{"key":"13528_CR7","doi-asserted-by":"publisher","unstructured":"Leli\u00e8vre J-D, Hocqueloux L. Unintended HIV-1 transmission to a sex partner in a study of a therapeutic vaccine candidate.\u00a0J Infect Dis. 2019;220(220 Suppl 1):S5-S6. https:\/\/doi.org\/10.1093\/infdis\/jiz012.","DOI":"10.1093\/infdis\/jiz012"},{"issue":"10","key":"13528_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/infdis\/jiz611","volume":"221","author":"A Ugarte","year":"2020","unstructured":"Ugarte A, Romero Y, Tricas A, Casado C, Garcia F, Leal L. Unintended HIV-1 infection during analytical treatment interruption. J Infect Dis. 2020;221(10):1740\u20132.","journal-title":"J Infect Dis"},{"issue":"32","key":"13528_CR9","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1073\/pnas.1810920115","volume":"115","author":"N Eyal","year":"2018","unstructured":"Eyal N, Lipsitch M, B\u00e4rnighausen T, Wikler D. Risk to study nonparticipants: a procedural approach. PNAS. 2018;115(32):8051\u20133.","journal-title":"PNAS."},{"issue":"Suppl 1","key":"13528_CR10","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/infdis\/jiz163","volume":"220","author":"N Eyal","year":"2019","unstructured":"Eyal N. How to address the risk of HIV transmission in remission studies with treatment interruption: the low-hanging fruit approach. J Infect Dis. 2019;220(Suppl 1):S7\u201311.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"13528_CR11","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1093\/infdis\/jiz090","volume":"220","author":"L Dawson","year":"2019","unstructured":"Dawson L. Human immunodeficiency virus transmission risk in analytical treatment interruption studies: relational factors and moral responsibility. J Infect Dis. 2019;220(Suppl 1):S12\u20135.","journal-title":"J Infect Dis"},{"key":"13528_CR12","doi-asserted-by":"publisher","unstructured":"Peluso MJ, Dee L, Shao S, Taylor J, Campbell D, Collins S, et al. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-Cov-2 pandemic: a collaborative approach. Clin Infect Dis.\u00a02021;72(10):1843-9. https:\/\/doi.org\/10.1093\/cid\/ciaa1260.\u00a0","DOI":"10.1093\/cid\/ciaa1260"},{"key":"13528_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25787489.2021.1883957","volume":"22","author":"K Dub\u00e9","year":"2021","unstructured":"Dub\u00e9 K, Kanazawa JT, Dee L, Taylor J, Campbell DM, Brown BJ, et al. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pr. 2021;22:1\u201317.","journal-title":"HIV Res Clin Pr"},{"issue":"1","key":"13528_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/aid.2014.0205","volume":"31","author":"R Johnston","year":"2015","unstructured":"Johnston R, Heitzeg M. Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review. AIDS Res Hum Retrovir. 2015;31(1):85\u201397.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"13528_CR15","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.jve.2020.100010","volume":"6","author":"L Barr","year":"2020","unstructured":"Barr L, Jefferys R. A landscape analysis of HIV cure-related clinical research in 2019. J Virus Erad. 2020;6(4):100010.","journal-title":"J Virus Erad"},{"key":"13528_CR16","doi-asserted-by":"publisher","unstructured":"Dub\u00e9 K, Kanazawa JT, Campbell C, Boone CA, Maragh-Bass A, Campbell DM, et al. Considerations for increasing racial, ethnic, gender and sexual diversity in HIV cure-related research with analytical treatment interruptions: a qualitative inquiry. AIDS Res Hum Retroviruses. 2022;38(1):50-63. https:\/\/doi.org\/10.1089\/AID.2021.0023. Epub 2021 May 31.","DOI":"10.1089\/AID.2021.0023"},{"issue":"12","key":"13528_CR17","doi-asserted-by":"publisher","first-page":"e0244490","DOI":"10.1371\/journal.pone.0244490","volume":"15","author":"T Poteat","year":"2020","unstructured":"Poteat T, Aqil A, Corbett D, Evans D, Dub\u00e9 K. \u201cI would really want to know that they had my back\u201d: transgender Women\u2019s perceptions of HIV cure-related research in the United States. PLoS One. 2020;15(12):e0244490.","journal-title":"PLoS One"},{"issue":"7","key":"13528_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/aid.2019.0021","volume":"35","author":"K Dub\u00e9","year":"2019","unstructured":"Dub\u00e9 K, Simoni J, Louella M, Sylla L, Mohamed ZH, Patel H, et al. Acceptability of cell and gene therapy for curing HIV infection among people living with HIV in the northwestern United States: a qualitative study. AIDS Res Hum Retrovir. 2019;35(7):649\u201359.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"9731","key":"13528_CR19","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","volume":"375","author":"D Donnell","year":"2010","unstructured":"Donnell D, Beaten J, Kiarie J, Thomas K, Stevens W, Cohen C, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092\u20138.","journal-title":"Lancet."},{"issue":"10","key":"13528_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/QAD.0000000000000307","volume":"28","author":"A Lasry","year":"2014","unstructured":"Lasry A, Sansom L, Wolitzki R, Green T, Borkowf C, Patel P, et al. HIV sexual transmission risk among Serodiscordant couples: assessing the effects of combining prevention strategies. AIDS. 2014;28(10):1521\u20139.","journal-title":"AIDS."},{"issue":"1","key":"13528_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.19.1.21224","volume":"19","author":"AJ Rogers","year":"2016","unstructured":"Rogers AJ, Achiro L, Bukusi EA, Hatcher AM, Kwena Z, Musoke PL, et al. Couple interdependence impacts HIV-related health Behaviours among pregnant couples in southwestern Kenya: a qualitative analysis. J Int AIDS Soc. 2016;19(1):1\u201310.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"13528_CR22","first-page":"e1046025","volume":"10","author":"H Scott","year":"2016","unstructured":"Scott H, Irvin R, Wilton R, Van Tieu H, Watson C, Magnus M, et al. Sexual behavior and network characteristics and their association with the bacterial sexually transmitted infections among black men who have sex with men in the United States. PLoS One. 2016;10(12):e1046025.","journal-title":"PLoS One"},{"issue":"65","key":"13528_CR23","first-page":"1","volume":"17","author":"JS Lau","year":"2020","unstructured":"Lau JS, Smith M, Allan B, Martinez C, Power J, Lewin S, et al. Acceptability, motivation and the Prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies. AIDS Res Ther. 2020;17(65):1\u20136.","journal-title":"AIDS Res Ther"},{"issue":"9","key":"13528_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/1049732313501889","volume":"23","author":"DL Morgan","year":"2013","unstructured":"Morgan DL, Ataie J, Carder P, Hoffman K. Introducing dyadic interviews as a method for collecting qualitative data. Qual Health Res. 2013;23(9):1276\u201384.","journal-title":"Qual Health Res"},{"issue":"12","key":"13528_CR25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1177\/1049732310376520","volume":"20","author":"Z Eisikovits","year":"2010","unstructured":"Eisikovits Z, Koren C. Approaches to and outcomes of dyadic interview analysis. Qual Health Res. 2010;20(12):1642\u201355.","journal-title":"Qual Health Res"},{"issue":"2","key":"13528_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","volume":"50","author":"I Ajzen","year":"1991","unstructured":"Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179\u2013211.","journal-title":"Organ Behav Hum Decis Process"},{"key":"13528_CR27","doi-asserted-by":"publisher","first-page":"e25404","DOI":"10.1002\/jia2.25404","volume":"22","author":"K Dub\u00e9","year":"2019","unstructured":"Dub\u00e9 K, Auerbach JD, Stirratt MJ, Gaist P. Applying the Behavioural and social sciences research (BSSR) functional framework to HIV cure research. J Int AIDS Soc. 2019;22:e25404.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"13528_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7748\/nr2011.01.18.2.52.c8284","volume":"18","author":"J Smith","year":"2011","unstructured":"Smith J, Firth J. Qualitative data analysis: the framework approach. Nurs Res. 2011;18(2):52\u201362.","journal-title":"Nurs Res"},{"issue":"1","key":"13528_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"key":"13528_CR30","doi-asserted-by":"publisher","unstructured":"Lau JSY, Smith MZ, Allan B, Martinez C, Power J, Lewin SR, et al. Perspectives on analytical treatment interruptions in people living with HIV and their health care providers in the landscape of HIV cure-focused studies. AIDS Res Hum\u00a0Retroviruses.\u00a02020;36(4):260-7. https:\/\/doi.org\/10.1089\/AID.2019.0118. Epub 2019 Dec 2.","DOI":"10.1089\/AID.2019.0118"},{"issue":"3","key":"13528_CR31","doi-asserted-by":"publisher","first-page":"e0229733","DOI":"10.1371\/journal.pone.0229733","volume":"15","author":"J Power","year":"2020","unstructured":"Power J, Dowsett GW, Westle A, Tucker JD, Hill S, Sugarman J, et al. The significance and expectations of HIV cure research among people living with HIV in Australia. PLoS One. 2020;15(3):e0229733.","journal-title":"PLoS One"},{"key":"13528_CR32","series-title":"WHO guidance on PrEP for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects","volume-title":"Guidance on PrEP for serodiscordant couples, men and tra1","author":"WHO","year":"2012","unstructured":"WHO. Guidance on PrEP for serodiscordant couples, men and tra1. WHO guidance on PrEP for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. 2012.nsge. 2012."},{"issue":"Suppl 1","key":"13528_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/jiz173","volume":"220","author":"N Eyal","year":"2019","unstructured":"Eyal N, Deeks SG. Risk to nonparticipants in HIV remission studies with treatment interruption: a symposium. J Infect Dis. 2019;220(Suppl 1):1\u20134.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"13528_CR34","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1007\/s10461-010-9802-0","volume":"14","author":"BR Karney","year":"2010","unstructured":"Karney BR, Hops H, Redding CA, Reis HT, Rothman AJ, Simpson JA. A framework for incorporating dyads in models of HIV-prevention. AIDS Behav. 2010;14(Suppl 2):S189\u2013203.","journal-title":"AIDS Behav"},{"issue":"7","key":"13528_CR35","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s10461-016-1423-9","volume":"20","author":"AA Conroy","year":"2016","unstructured":"Conroy AA, Gamarel KE, Neilands TB, Dilworth SE, Darbes LA, Johnson MO. Relationship dynamics and partner beliefs about viral suppression: a longitudinal study of male couples living with HIV\/AIDS (the duo project). AIDS Behav. 2016;20(7):1572\u201383.","journal-title":"AIDS Behav"},{"issue":"1","key":"13528_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10461-018-2275-2","volume":"23","author":"AA Conroy","year":"2019","unstructured":"Conroy AA, McKenna SA, Ruark A. Couple interdependence impacts alcohol use and adherence to antiretroviral therapy in Malawi. AIDS Behav. 2019;23(1):201\u201310.","journal-title":"AIDS Behav"},{"issue":"4","key":"13528_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11904-014-0225-9","volume":"11","author":"K Muessig","year":"2014","unstructured":"Muessig K, Cohen M. Advances in HIV prevention for Serodiscordant couples. Curr HIV\/AIDS Rep. 2014;11(4):434\u201346.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"13528_CR38","first-page":"181","volume":"71","author":"MJ Curno","year":"2016","unstructured":"Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of Antiretrovirals and vaccines to cure strategies. JAIDS. 2016;71(2):181\u20138.","journal-title":"JAIDS."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13528-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T05:07:24Z","timestamp":1657343244000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13528-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13528"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13528-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Charles R. Drew University of Medicine and Science (CDU) and the University of North Carolina at Chapel Hill (UNC-CH) IRBs approved the study. Informed consent was obtained from all individual participants included in this study. All methods were carried out in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants provided consent to publish de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.D. has received funding from Gilead Sciences, Inc. and Merck & Co., Inc. that is not directly related to this study. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1317"}}